The sudden and severe US cuts to grants from the world’s largest health research funder threaten to unravel the medical research landscape in South Africa. A crucial question now is whether the government will turn this crisis into an opportunity for renewal, write Marcus Low and Nathan Geffen.
Following President Donald Trump’s decision to suspend foreign aid, President Cyril Ramaphosa can display great leadership by meeting with leaders of wealthy countries and convincing them to increase spending to support the health systems of poorer countries, write Nathan Geffen and Marcus Low.
Hillbrow started out as Johannesburg’s first health hub in the late 1880s. It’s also been a suburb associated with pimps and prostitution, a middle finger to the Nationalist Party, and a key site of the HIV crisis. Today, it’s the forgotten flatlands of inner city decay … but in small pockets it stays true to its heritage of bringing healthcare to the city’s most overlooked.
South Africa is seeing fewer medication stockouts than in previous years but contraception shortages continue to be a problem in the country, according to a new report from the Stop Stockouts Project. Injectables, the most widely used method in South Africa, accounted for three-quarters of contraception stockouts reported. Aisha Abdool Karim unpacks what this means for women’s sexual and reproductive health.
Even though the rate of new HIV infections in young women and adolescent girls remains stubbornly high, provision and uptake of pills that can prevent HIV infection have generally been slow and lagging. One potential solution presented at the recent Conference on Retroviruses and Opportunistic Infections is to provide the pills at schools. Tiyese Jeranji reports.
There is no time to waste in planning the South African rollout of cabotegravir (CAB LA), the long-lasting antiretroviral injection approved for use in the United States in December 2021, say local health experts.
There are a variety of tools available today to prevent pregnancy including pills, intrauterine devices, subdermal implants, injections, condoms, male and female sterilisation, and emergency contraception. Statistics suggest that people in South Africa do, in principle at least, have access to and are aware of these contraceptive methods, albeit not at the desired levels. Elna Schütz looks at what contraceptive methods are available and makes some surprising discoveries along the way about which ones are most popular.
A study recently published in The Lancet found that women living with HIV made up an astonishing 63.4% of new cervical cancer cases in South Africa in 2018. Elri Voigt spoke to local experts about the links between HIV and cervical cancer in South Africa and how cervical cancer is prevented, tested for, and treated in the public sector.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
